Tocilizumab in Behcet’s disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes - Atienza-Mateo, B; Beltran, E; Hernandez-Garfella, M (Clin Exp Rheumatol, 2021)
et al.